1258009-16-3

Basic information

• Product Name: 4-(1-cyclohexyl-4-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}-1H-pyrazol-5-yl)pyridine
• Synonyms: 4-(1-cyclohexyl-4-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}-1H-pyrazol-5-yl)pyridine
• CAS NO: 1258009-16-3
• Molecular Weight: 439.44
• Mol File: 1258009-16-3.mol

Chemical Properties

• CAS DataBase Reference: 4-(1-cyclohexyl-4-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}-1H-pyrazol-5-yl)pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(1-cyclohexyl-4-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}-1H-pyrazol-5-yl)pyridine(1258009-16-3)
• EPA Substance Registry System: 4-(1-cyclohexyl-4-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}-1H-pyrazol-5-yl)pyridine(1258009-16-3)

Safety Data

• Hazardous Substances Data: 1258009-16-3(Hazardous Substances Data)

Upstream product

• 1258008-62-6 ethyl 1-cyclohexyl-5-pyridin-4-yl-1H-pyrazole-4-carboxylate 
• 40067-80-9 N'-hydroxy-3-(trifluoromethyl)benzenecarboximidamide 

Relevant articles and documents

PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS

The present invention relates to pyrazole oxadiazoles derivatives of Formula (I), and their use for treating multiple sclerosis and other diseases. Wherein R1, R2 and R3 are as defined in the description.